(Total Views: 60)
Posted On: 10/05/2023 12:20:47 PM
Post# of 107225
$NBIX News Article - Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary Endpoints https://marketwirenews.com/news-releases/neur...02042.html
(0)
(0)
My Twitter: WhyteStocks
